HHS - National Vaccine Program Office (NVPO): Research: Awards

National Vaccine Program Office Inter-Agency Vaccine Group Research Program Awards for Fiscal Year 2003
Principal Investigator(s) (click link for PI info.)	Institution	Proposal Number (Abstract Link)	Proposal Title
Awasthi, Shally	U.S. Agency for International Development	N55	Association of Intestinal Intussusception and Diarrhoea: Six-Country Surveillance
Ball, Robert	Food and Drug Administration	C23	Arthritis after Lyme Vaccine: Case Control Study
Beall, Bernard	Centers for Disease Control and Prevention	C3	Molecular Surveillance Within Year 2002 and 2003 Invasive Pneumococcal Isolates for Capsular Switching Events from 7 Valent Conjugate Vaccine Serotypes to Those not Covered by This Vaccine
Bell, Beth P.	Centers for Disease Control and Prevention	N36	Estimating Hepatitis A Vaccine Coverage Among Children Living in States Where Routine Vaccination is Recommended
Bernier, Roger	Inter-Agency Vaccine Group	C19	Improving Public Participation in Dialogue and Deliberation About Vaccines
Breese, Joseph; Tu, Van Phan.; Nguon, Huynh Vinh Hai	Centers for Disease Control and Prevention	C5	Determination of the Epidemiology of and Risk Factors of and Validation of Clinical Case Definitions for Intussusception Among Infants in Ho Chi Minh City, Vietnam
Breiman, Robert; Fukuda, Keiji	Centers for Disease Control and Prevention	N30	Influenza Surveillance and Estimate of the Burden of Influenza in Bangladesh
Breiman, Robert; Zaman, K.	U.S. Agency for International Development	N56	Defining Incidence of IS in Bangladesh in Preparation for a Phase III trial of a New Rotavirus Vaccine
Brennan, Michael J.	Food and Drug Administration	N70	Development of Novel Recombinant Vaccine to Treat Adult Pulmonary Tuberculosis
Cannon, Michael; Inoue, Naoki; Schmid, Scott	Centers for Disease Control and Prevention	N26	Congential Cytomegalovirus (CMV) Epidemiology and Diagnostics Development
Cardo, Denise; Jernigan, John	Centers for Disease Control and Prevention	C11	Assessing the Impact of Influenza Vaccination Programs in Acute and Long-term Healthcare Facilities
Cetron, Martin S.	Centers for Disease Control and Prevention	N17	Yellow Fever Vaccine-Associated Adverse Event Surveillance and Risk Assessment
Chumakov, Konstantin	Food and Drug Administration	N67	Advanced Immunological Techniques for Analysis of Polivirus Vaccines and Vaccine-Derived Polioviruses
Chumakov, Konstantin	Food and Drug Administration	C22	Rapid Microarray Screening of Vaccine-Derived Polioviruses
Curtis, Christine	Centers for Disease Control and Prevention	C15	Source of Bordetella Pertussis Among Infants with Whooping Cough
Dowdle, Walter	National Vaccine Program Office; Centers for Disease Control and Prevention	C18	U.S. Polio Laboratory Containment Survey
Epstein, Suzanne	Food and Drug Administration	N65	Influenza Pandemic Preparedness: Vaccination with Conserved Influenza Virus A Components by DNA Prime-Viral Boost Regimens
Fast, Patricia	National Vaccine Advisory Committee	N41	Workshop: Pneumococcal Disease Prevention in Adults -- Potential Vaccine Strategies
Feikin, Daniel	Centers for Disease Control and Prevention	C10	Enhancing Response to Haemophilus Influenzae Type b Conjugate Vaccine Among Kenyan Infants Through Intermittent Malaria Prophylaxis
Feinstone, Stephen	Food and Drug Administration	C20	A Chimeric Mouse Model for the Progagation of Hepatitis C Virus
Fisbein, Daniel	Centers for Disease Control and Prevention	C16	Effectiveness of an Assessment/Reminder and Cost Subsidy on Vaccination of Adolescents and Adults in Non-Traditional Settings
Gust, Deborah	Centers for Disease Control and Prevention	C14	NVPO 2002 - Understanding Parental Uncertainty Regarding Childhood Immunization: An NIS Module of Parental Knowledge, Attitudes and Beliefs NVPO Continuation Project 2002 - Educational Material Design and Testing for Audience Segments of Parents Based Upon Health and Immunization Attitudes and Beliefs
Hennessy, Thomas	Centers for Disease Control and Prevention	C13	Impact of Pneumococcal Conjugate Vaccine on Carriage of Streptococcus Pneumoniae in Rural Alaska Native Communities
Hughes, Hayley	Centers for Disease Control and Prevention	N45	Evaluating the Feasibility of a Pediatric Hospital-Based Sentinel Surveillance Network for Vaccine Preventable Diseases
Hutin, Yvan	U.S. Agency for International Development	N54	A Standardized Procedure to Assess Technologies Relevant to Immunization Programmes for Potential Inclusion into a WHO Model List of Essential Equipment
Iwane, Marika K.	Centers for Disease Control and Prevention	N46	Identifying Risk Factors for Severity of Influenza and RSV Illness: Comparative Study of Inpatients, Outpatients, and Well Children
Jumann, Aisha O.	Centers for Disease Control and Prevention	N50	Surveillance for Varicella and Herpes Zoster in VSD Populations
Karem, Kevin L.; Unger, Elizabeth R.	Centers for Disease Control and Prevention	N20	Validation of Noninvasive Method for Monitoring Immune Response to Human Papillomavirus
Katz, J.; Sambhara, S.	Centers for Disease Control and Prevention	N27	Use of Novel Immunodulators and Delivery Strategies to Enhance Immunogenicity and Efficacy of Pandemic Vaccines in Mice
Kohl, Katrin	Centers for Disease Control and Prevention	N52	Comprehensive Evaluation of Applicability, Reliability, Sensitivity, and Specificity of Newly Developed Standardized Case Definitions for Adverse Events Following Immunization
Krause, Philip	Food and Drug Administration	N60	Development of Nanobiosensor for Detecting Adventitious Viral Agents in Vaccines
Levis, Robin; Weir, Jerry	Food and Drug Administration	N66	Development of Improved Assays for Evaluating Vaccines Against West Nile Virus and Other Emerging Viral Pathogens
Lewis, Andrew	Food and Drug Administration	C21	Evaluation of VERO Cell Evolution from a Nontumorigenic to a Tumorigenic Phenotype
Lewis, Andrew; Peden, Keith	Food and Drug Administration	N59	Follow-up Studies on the Detection of SV40 in Environmental Samples: Is SV40 a Human Infectious Agent?
Longini, Ira	National Institutes of Health	C2	Statistical and Mathematical Modeling of the Use of Limited Supplies of Antiviral Agents for Pandemic Influenza
Loparev, Vladimir; Schmid, Scott	Centers for Disease Control and Prevention	N25	Evaluation of Potentially Virulent Mutations in Oka Vaccine Substrains Associated with Adverse Events and in Wild-Type Strains Associated with High Rates of Vaccine Breakthrough Infection
Meysick, Karen	Food and Drug Administration	N69	Identification of Potential Vaccine Antigen Candidates Associated with a Novel Yersinia Pestis Chromosomal Type III Secretion System
Murphy, Trudy V.	Centers for Disease Control and Prevention	N80	An Assessment of Neonatal Vaccination with Current and Future Vaccines
Rosenstein, Nancy	Centers for Disease Control and Prevention	N31	Evaluation of the Serogroup W135 Meningococcal Polysaccharide Vaccine as a Control Measure for Meningococcal Epidemics in an African "Meningitis Belt" Country
Rubin, Fran A.	National Institutes of Health	N12	Workshop to Discuss Prevention of Group A Streptococcal Diseases and Their Sequelae with a Focus on Vaccine Related Issues
Rubin, Steven	Food and Drug Administration	N57	Valdiation of the Newborn Rat Neurovirulence Assay for Mumps Virus Vaccines
Rupprect, C.E.	Centers for Disease Control and Prevention	C4	Utility of Intradermal Multi-Site Vaccine Application in Rabies Prophylaxis
Sampson, Jacquelyn	Centers for Disease Control and Prevention	N19	Development of a Novel Streptococcus Pneumoniae Microarray for Detection of Pneumococci, Antibotic Sensitivity, and Diagnosis of Pneumococcal Disease
Schleiss, Mark R.	National Institutes of Health	N10	Epidemiology of Cytomegalovirus (CMV) Infection in Children Attending Day Care Centers in Cincinnatti, Ohio: Application to CMV Vaccine Studies
Schmaljohn, Connie	Department of Defense	N2	Multiagent DNA Vaccines
Schmid, D. Scott	Centers for Disease Control and Prevention	C7	Comparison of Cell-Mediated Immune Responses to Natural VZV infection and Oka Vaccine Using Fluorescent-Microsphere-Based Multiplex Cytokine Analysis
Schrag, Stephanie	Centers for Disease Control and Prevention	N34	Characterizing the Need for Maternal or Adolescent Group B Sstreptococcal Vaccination in a Developing Country Setting: Assessment of Disease Burden and Access to Care at Chri Hani Baragwanath Hospital, Soweto, South Africa
Schrag, Stephanie; Schuchat, Anne	Centers for Disease Control and Prevention	C12	Group B Streptococcal Vaccine Development: Characterization of Invasive Disease Strains
Shay, David K.	Centers for Disease Control and Prevention	N49	Evaluation of Neuropsychological Outcomes Among Children Randomly Exposed to Differing Amounts of Thimerosal During Infancy: Follow-up of Italian DTaP Trial Participants
Singleton, James	Centers for Disease Control and Prevention	C17	Rapid Annual Assessment of Influenza Vaccine Utilization Among Adults
Stokley, Shannon	Centers for Disease Control and Prevention	N39	Provider Response to Vaccine Shortages and the Ability to Recall Children
Terebuh, Pauline	Centers for Disease Control and Prevention	C8	Transmission of Influenza Viruses Between Pigs and Humans in Iowa
Tripp, Ralph	Centers for Disease Control and Prevention	C6	Characterization of the CX3C Chemokine-Like Region in the G Glycoprotein of Respiratory Syncytial Virus
Uyeki, Timothy	Centers for Disease Control and Prevention	C9	Effectiveness of Maternal Influenza Vaccination to Prevent Influenza in Infants
Whitney, Cynthia	Centers for Disease Control and Prevention	N18	Population-Based Surveillance to Identify the Impact of Introduction of Pneumococcal Conjugate Vaccine (PCV7) on the Occurrence of Radiographically-Confirmed Pneumonia in Adults
Wortley, Pascale	Centers for Disease Control and Prevention	N42	Updating Influenza Pandemic Preparedness and Response Planning: Development of Table Top Exercises for State and Local Planning
Zollinger, Wendell	Department of Defense	N19	Production and Evaluation of a Clinical Lot of Meningococcal Native Outer Membrane Vesicle Vaccine Prepared from a Strain with Genetically Detoxified Lipopolysaccharide